🇺🇸 FDA
Pipeline program

BIS-001ER

BNI-02-1b

Phase 2 small_molecule active

Quick answer

BIS-001ER for Focal Impaired Awareness Seizures is a Phase 2 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SUPERNUS PHARMACEUTICALS, INC.
Indication
Focal Impaired Awareness Seizures
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials